Locations:
Search
Cleveland Clinic and PGDx employ liquid biopsy technology to enhance patient care and research
BACE1 inhibitor reduces cancer progression in models of glioblastoma
Common cancer therapy increases serious risks in murine models
69% relative risk reduction in large database analysis prompts plans for mechanistic and phase 2 studies
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Provocative findings from a hypothesis-generating study
Understudied Src Family Kinase may serve as a potential therapeutic target
Dr. Anand-Apte named Chair for Ophthalmology Research
Findings implicate hydrogen sulfide dysfunction, point to potential treatment strategies
Retired-protein strategy represents new approach to immunization
22,000-square-foot facility boosts biobanking capacity for research projects
Advertisement
Advertisement